跳至主要内容
临床试验/NCT04232228
NCT04232228终止不适用

A UK Observational Study to Evaluate the Impact of Care4Today® IBD, a Smart System to Facilitate the Management of Crohn's Disease by Patients and Health Care Providers

Janssen-Cilag Ltd.1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2020年2月7日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
32
试验地点
1
主要终点
Crohn's Disease Related Secondary Health Related Utilization (HRU) in the 6 Months Pre-Activation of Care4Today® Inflammatory Bowel Disease (C4T IBD) Application (Pre-Index)

研究概览

简要总结

The purpose of this study is to describe the Crohn's Disease (CD)-related secondary healthcare resource utilisation of patients in the 6 months pre- and 12 months post-activation of Care4Today® inflammatory bowel disease (C4T IBD) alongside standard of care (SOC) in the management of CD.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants with moderate to severe Crohn's disease (CD), diagnosed at least 6 months prior to index date, as documented by the treating healthcare professional (HCP)
  • Participants with at least 6 months of continuous care in the study centre prior to index date
  • Participants who have agreed to install Care4Today® inflammatory bowel disease (C4T IBD) on their iOS or android smartphone as part of their management of CD
  • Participants providing informed written consent to participate in the study from the date of activation (including installation and linkage to HCP web interface) of the C4T IBD app on his/her smartphone

排除标准

  • Participants with presence of ileorectal or ileal pouch-anal anastomosis documented in their medical records
  • Participants in remission for over 2 years as documented in their medical records
  • Participants participating in an interventional clinical trial
  • Participants participating in an observational study where the protocol interferes with the C4T study in the opinion of the principal investigator at each site
  • Participants with insufficient command of English to interact effectively with C4T IBD and complete the study questionnaires in the opinion of the principal investigator at each site
  • Participants unable or unwilling to provide their informed written consent to participate in the study

结局指标

主要结局

Crohn's Disease Related Secondary Health Related Utilization (HRU) in the 6 Months Pre-Activation of Care4Today® Inflammatory Bowel Disease (C4T IBD) Application (Pre-Index)

时间窗: 6 months pre-index of C4T IBD application

The number of gastroenterology health care provider (HCP) contacts per participant in the 6 months pre-index will be reported. Index is the activation date of C4T IBD application in participant's smartphone.

Crohn's Disease Related Secondary HRU in the 12 Months Post-Activation of C4T IBD Application (post-index)

时间窗: Up to 12 months post index of C4T IBD application

The number of gastroenterology HCP contacts per participant in the 12 months post-index will be reported. The 12 months post-index period will be split into two time periods: 0-6 months post-index and 6-12 months post-index. The 0-6 and 6-12 month post-index periods will be described separately.

次要结局

  • Crohn's Disease (CD)-Related Primary Healthcare Resource Utilization(6 months pre- and 12-months post-index)
  • Number of Participants with Characteristics Including Duration of Disease, Current Treatments and Previous Treatments(At screening (during 6 months pre-index))
  • Disease Activity of Participants Measured Using the Harvey-Bradshaw Index (HBI) or Modified HBI(6 months pre- and 12 months post-index)
  • Disease Activity of Participants Measured Using Markers of Systemic Inflammation(6 months pre- and 12 months post-index)
  • Disease Progression of Participants Measured Using the Fatigue Severity Scale (FSS)(Up to 12 months post-index)
  • Impact of C4T IBD on Participant's Level of Engagement with Their Disease Measured Using the Patient Activation Measure (PAM)(Up to 12 months post-index)
  • Disease Progression of Participants Measured Using Number of Bowel Movements(Up to 12 months post-index)
  • Disease Progression of Participants Measured by Level of Abdominal Pain(Up to 12 months post-index)
  • Impact of C4T IBD on Health Related Quality of Life (HRQoL, General and Inflammatory Bowel Disease [IBD] Specific) and Productivity(Up to 12 months post-index)
  • Patient- and HCP-Reported Satisfaction(Up to 12 months post-index)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验